TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry | #o | #f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/18/26 16:14 | 8/15/26 | QDEL | Quidelortho Corp | Health | Diagn | In Vitro & In Vivo Diagnostic | 1 | 2 | M.d | 0 | 0.00 | 0 | 6 | 345 | 8 | D | |||||||||||||||
8/6/26 08:16 | 8/4/26 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | 1 | 1 | P | 4 | 11.81 | 0 | 0 | 53 | 1 | I | ||||||||||||||
7/24/26 17:26 | 7/1/26 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | 2 | 3 | S | -220 | 14.24 | 0 | -15 | 223 | D | |||||||||||||||
6/22/26 08:33 | 6/18/26 | ICCC | Immucell Corp /De/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | 1 | 1 | P | 76 | 9.50 | 0 | 8 | 82 | 18 | D | ||||||||||||||
6/9/26 16:53 | 6/5/26 | AWHL | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | 3 | 3 | P.d | 132 | 0.4500 | 0 | 294 | 6 | 5,353 | I | ||||||||||||||
6/9/26 16:20 | 6/8/26 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | 1 | 1 | S | -67 | 4.46 | 0 | -15 | 172 | D | |||||||||||||||
6/2/26 17:00 | 6/1/26 | IDXX | Idexx Laboratories Inc /De | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | 1 | 1 | M.d | 0 | 0.00 | 0 | 1 | 7 | 10 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |